Colman Domingo, Dev Patel rumored to be eyed for new Jurassic World movie

Colman Domingo and Dev Patel are rumored to be eyed for the new Jurassic World movie directed by...

Devon Sawa wants an Idle Hands / Chucky crossover

Devon Sawa has come across the horror crossover we didn’t know we needed: Chucky vs. the possessed hand...

Latest News

Real Estate

Medicine & Health

Celeb News

LA ROCHE-POSAY ANNOUNCES SPONSORSHIP OF THE MIAMI OPEN AS FIRST-EVER OFFICIAL SUNSCREEN TO RAISE AWARENESS OF SUN SAFE PRACTICES

NEW YORK, March 19, 2024 /PRNewswire/ -- La Roche-Posay and IMG are excited to announce that La Roche-Posay has signed on to become the official sunscreen...

Operation Smile Announces the Return of the 12th Annual Celebrity Ski & Smile Challenge in Park City, Utah

PARK CITY, Utah, March 19, 2024 /PRNewswire/ -- Operation Smile, the world-renowned volunteer medical organization dedicated to providing cleft surgery and comprehensive care to...

NEBULA ANNOUNCES BIGGEST UPDATE YET INCLUDING “NEBULA NEWS” AND LATEST SLATE OF ORIGINALS

The largest and fastest-growing creator-built streaming service announces its latest expansion into news with "Nebula News" in partnership with TLDR as well as its...

DARK & LOVELY LAUNCHES ‘PLAY IN COLOR’ CAMPAIGN IN CELEBRATION OF BLACK BEAUTY AND EXPRESSION

#1 Hair Color Brand's Multi-Phase Campaign Includes the Expansion of Fade Resist Portfolio with New, Vibrant, Immersive ColorsNEW YORK, March 20, 2024 /PRNewswire/ --...

Latest Articles

Grammy Nominee Ondara Wins Grand Prize in International Songwriting Competition (ISC)

Judges include Coldplay, The Lumineers, Linkin Park, Tom Waits, Rosanne Cash, Needtobreathe, Sara Evans, Danilo Perez, ACraze, and MoreNASHVILLE, Tenn., May 10, 2023 /PRNewswire/...

Medicus IT Appoints Industry Veteran to Key Leadership Role

Medicus IT is proud to announce the promotion of Nelson Gomes to Executive Vice President of Business Development. Nelson Gomes Nelson Gomes Exec...

Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-Powered Life Sciences Solutions

Google Cloud's Multiomics Suite Delivers Powerful AI and Bioinformatics Tools for Biotech Companies, Pharmaceutical Firms, and Public Sector Organizations

Form Bio, the breakthrough computational life sciences platform, announced today that it has been selected to help organizations adopt Google Cloud's Multiomics Suite, accelerating the research of life science companies and academic institutions. In addition, Form Bio has been designated by Google as a Google Cloud Premier partner.

Multiomics provides an integrated perspective to power discovery across life sciences research domains. Organizations will have an option to incorporate Form Bio's innovative platform when adopting Google Cloud's Multiomics Suite, to empower the next wave of innovative life science research. The collaboration with Google Cloud will combine ease of use with comprehensive analysis of genetic and proteomic data, expediting biopharmaceutical research. 

Google Cloud's Multiomics Suite accelerates the discovery, integration, and interpretation of data, allowing for increased research efficiency. When combined with the Form Bio platform customers can have even greater robust data management, streamlined workflows, and optimized collaboration approaches. Form Bio's groundbreaking software: 

  • Enables discovery, sharing and interpretation of genomic data 
  • Allows AI models to be built at scale with the rigorous traceability and reproducibility required for advanced research.
  • Offers a streamlined environment for intuitive analysis.

This new collaboration is a natural fit for Form Bio, with its founding mission to help scientists drive their next breakthroughs. 

"Surging interest in bioinformatics and AI is inspiring a wave of life science companies to turn to cloud-based computing," said Mark Swendsen, Chief Revenue Officer for Form Bio. "Form Bio has a team of industry experts and is built on Google Cloud's advanced high performance computing, data analytics, and AI technology, putting us ahead of the curve." 

"With Google Cloud's powerful platform, Form Bio is positioned to increase life sciences research data accessibility, ease of use, and interpretability. Through this alliance with Google Cloud, we will be able to drive automation and optimization for the industry, empower life sciences researchers to accelerate their breakthroughs and broaden our scope and reach for the science and academic communities," added Swendsen.

Premier partner status in the Google Cloud Partner program is designed to provide Google Cloud clients with qualified partners, like Form Bio, that demonstrate technical proficiency and proven success in specialized service areas. To learn more about Form Bio's platform and solutions, visit formbio.com.

Additional Resources:


About Form Bio

Form Bio is a life sciences focused software company dedicated to empowering scientific discovery and enabling a new era of insights and breakthroughs. With an award-winning, easy-to-use research and discovery platform as well as powerful AI solutions for specific biopharma challenges, Form Bio accelerates therapeutic research, design and development. In addition to providing innovative technology, Form Bio works collaboratively with customers to advance their most ambitious scientific objectives, offering unmatched, cross-disciplinary expertise spanning software engineering, biology, bioinformatics and data science. For more information on Form Bio, visit formbio.com.

Contact Information:
Maggie Whitney
Senior Public Relations Executive
[email protected]
2039571502

Alison Guzzio
Public Relations Director
[email protected]
4844593243


Original Source: Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-Powered Life Sciences Solutions Form Bio Selected by Google Cloud to Help Organizations Adopt New AI-Powered Life Sciences Solutions

Idris Elba to star in and direct action thriller Infernus

Idris Elba will star in, produce, and direct Infernus, an action thriller in development for Millennium Media. According to Deadline, Idris Elba is set to...